Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 670743, 10 pages
Research Article

Cryptotanshinone Reverses Reproductive and Metabolic Disturbances in PCOS Model Rats via Regulating the Expression of CYP17 and AR

1Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Shanghai 200433, China
2Traditional Chinese Medicine University of Shanghai, Shanghai 201203, China
3Basic Medical College, Henan College of Traditional Chinese Medicine, Zhengzhou 450008, China
4Department of Biochemistry and Molecular Biology, 800 Xiangyin Road, Second Military Medical University, Shanghai 200433, China

Received 3 January 2014; Accepted 27 February 2014; Published 3 April 2014

Academic Editor: Yemeng Chen

Copyright © 2014 Jin Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. C. J. M. Fauser, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,” Fertility and Sterility, vol. 81, no. 1, pp. 19–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. M. Sirmans and K. A. Pate, “Epidemiology, diagnosis, and management of polycystic ovary syndrome,” Clinical Epidemiology, vol. 6, pp. 1–13, 2014. View at Google Scholar
  3. M. O. Goodarzi, D. A. Dumesic, G. Chazenbalk, and R. Azziz, “Polycystic ovary syndrome: etiology, pathogenesis and diagnosis,” Nature Reviews Endocrinology, vol. 7, no. 4, pp. 219–231, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. X.-Y. Ji, B. K.-H. Tan, and Y.-Z. Zhu, “Salvia miltiorrhiza and ischemic diseases,” Acta Pharmacologica Sinica, vol. 21, no. 12, pp. 1089–1094, 2000. View at Google Scholar · View at Scopus
  5. X. Wang, S. L. Morris-Natschke, and K.-H. Lee, “New developments in the chemistry and biology of the bioactive constituents of Tanshen,” Medicinal Research Reviews, vol. 27, no. 1, pp. 133–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Anderson, G. Y. Lee, and K. Obrein, “Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles,” The Anatomical Record, vol. 249, no. 1, pp. 44–53, 1997. View at Google Scholar
  7. M. T. Lee, E. Anderson, and G. Y. Lee, “Changes in ovarian morphology and senlm hormones in the rat after treatment tll dehydrcepiandrosterone,” The Anatomical Record, vol. 231, no. 2, pp. 185–192, 1991. View at Google Scholar
  8. X. Yang, Y. Zhang, X. Wu et al., “Cryptotanshinone reverses reproductive and metabolic disturbances in prenatally androgenized rats via regulation of ovarian signaling mechanisms and androgen synthesis,” American Journal of Physiology, Regulatory Integrative and Comparative Physiology, vol. 300, no. 4, pp. R869–R875, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. He, C. Zuo, J. Wang et al., “Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma,” Neuro-Oncology, vol. 15, no. 6, pp. 727–734, 2013. View at Publisher · View at Google Scholar
  10. J. M. Hur, J. S. Shim, H. J. Jung, and H. J. Kwon, “Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro,” Experimental and Molecular Medicine, vol. 37, no. 2, pp. 133–137, 2005. View at Google Scholar · View at Scopus
  11. L. Zhou, Z. Zuo, and M. S. S. Chow, “Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use,” Journal of Clinical Pharmacology, vol. 45, no. 12, pp. 1345–1359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D.-Z. Jin, L.-L. Yin, X.-Q. Ji, and X.-Z. Zhu, “Cryptotanshinone inhibits cyclooxygenase-2 enzyme activity but not its expression,” European Journal of Pharmacology, vol. 549, no. 1-3, pp. 166–172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. K. Eun, S.-N. Jung, H. S. Kun et al., “Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase,” Molecular Pharmacology, vol. 72, no. 1, pp. 62–72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Qi, J. X. Song, L. Yang et al., “Studies on effect of cryptotanshinone on insulin resistant ovarial granular cells by DNA microarray,” Technology Review, vol. 27, pp. 39–40, 2009. View at Google Scholar
  15. The Practice Committee of the American Society for Reproductive Medicine, “The evaluation and treatment of androgen excess,” Fertility and Sterility, vol. 86, no. 5, pp. S241–S247, 2006. View at Google Scholar
  16. H.-Y. Kuang, H. Shao, L.-H. Hou, and X.-K. Wu, “Effects of ginseng total saponins on nerve growth factor expression in rat with estradiol valerate-induced polycystic ovaries,” Journal of Chinese Integrative Medicine, vol. 6, no. 7, pp. 723–728, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Le, X. Xie, Z. Q. Lin et al., Gynaecology, vol. 5, Press of Renmin Weisheng, Beijing, China, 7th edition, 2009.
  18. J. E. Nestler, L. P. Powers, D. W. Matt et al., “A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 1, pp. 83–89, 1991. View at Google Scholar · View at Scopus
  19. L.-N. Jia and X.-J. Wang, “Clinical observation on treatment of 43 women polycystic ovary syndrome based on syndrome differentiation,” Journal of Chinese Integrative Medicine, vol. 4, no. 6, pp. 585–588, 2006. View at Google Scholar · View at Scopus
  20. R. Azziz, R. S. Rittmaster, L. M. Fox, E. L. Bradley Jr., H. D. Potter, and L. R. Boots, “Role of the ovary in the adrenal androgen excess of hyperandrogenic women,” Fertility and Sterility, vol. 69, no. 5, pp. 851–859, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. G. M. Reaven, Y.-D. I. Chen, J. Jeppesen, P. Maheux, and R. M. Krauss, “Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles,” The Journal of Clinical Investigation, vol. 92, no. 1, pp. 141–146, 1993. View at Google Scholar · View at Scopus